Human B19 parvovirus recombinant capsid proteins VP1 and VP2 were expressed in E. coli and purified. Recombinant proteins were used to detect a specific IgG immune response against VP1 and VP2 linear epitopes by immunoblot assay. A total of 222 serum samples from 218 apparently immunocompetent subje
Epitope Type-Specific IgG Responses to Capsid Proteins VP1 and VP2 of Human Parvovirus B19
β Scribed by Soderlund, M.; Brown, C. S.; Spaan, W. J. M.; Hedman, L.; Hedman, K.
- Book ID
- 125861466
- Publisher
- University of Chicago Press
- Year
- 1995
- Tongue
- English
- Weight
- 597 KB
- Volume
- 172
- Category
- Article
- ISSN
- 0022-1899
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In the B19 VP2 molecule an immunodominant heptapeptide epitope has been detected, recently for which IgG antibodies are synthesized exclusively in the acute phase of B19 infection. Using this acuteβphaseβspecific epitope (KYVTGIN) a 2^nd^βgeneration epitopeβtype EIA was developed, which
## Abstract The IgM immune response against conformational and linear epitopes of B19 structural proteins VP1 and VP2 was examined in serum samples with a suspect B19 infection to determine the most suitable antigen for use in IgM detection and also to evaluate a possible relationship between the c
## Abstract Parvovirus B19 infection occurs very frequently in patients with haemophilia on account of its transmission with plasma derivatives. In order to achieve a more defined serological pattern for the study of the role of B19 infection in haemophilic arthritis, 53 serum samples from 37 patie